✦ LIBER ✦

all-trans retinoic acid for treating germ cell tumors. In vitro activity and results of a phase II trial

✍ Scribed by Mark M. Moasser; Robert J. Motzer; Kei-Siong Khoo; Peter Lyn; Barbara A. Murphy; George J. Bosl; Ethan Dmitrovsky

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 677 KB
Volume: 76
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19950815)76:4<680::aid-cncr2820760423>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Suramin for germ cell tumors. In vitro g

Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trial

✍ Robert J. Motzer; Ethan Dmitrovsky; Wilson H. Miller Jr.; William P. Tong; Dean 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

A Phase II study of all-trans-retinoic a

A Phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma : An Eastern Cooperative Oncology Group study

✍ Gregory P. Kalemkerian; Michael Jiroutek; David S. Ettinger; John A. Dorighi; Da 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.

Interferon-α-2a with or without 13-cis r

Interferon-α-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma : Results of a randomized Phase II study (European Organization for Research and Treatment of Cancer Study 30951)

✍ Sophie D. Fosså; Gerald H. J. Mickisch; Pieter H. M. De Mulder; Simon Horenblas; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

## Background: In patients with metastatic renal cell carcinoma (mrcc), interferon-alpha (ifn) monotherapy leads to response rates of 5-15%, dependent on the selection of patients. in 1995, preclinical and clinical data indicated an improvement of these results if ifn was combined with 13-cis retin